The long-term goal of this project is to understand the mechanism by which 4-hydroxyalkenals and related aldehydes are detoxified by the heart and to assess their contribution to myocardial oxidative injury. These aldehydes are generated by endogenous lipid peroxidation during metabolism of anticarcinogens, food products and industrial and environmental pollutants. However, the cardiac metabolism of these aldehydes and their contribution to free radical injury are not well understood. Our hypothesis is that aldose reductase-catalyzed reduction constitutes the major pathway for the detoxification of these aldehydes in the heart. In association with glutathione conjugation, this pathway minimizes oxidative injury by promoting the detoxification of unsaturated aldehydes.
The aim of the proposed studies is to understand the role of aldose reductase in detoxifying unsaturated aldehydes and to identify the contribution of this detoxification pathway to cardiac antioxidant defenses. For these studies, aldose reductase will be purified to homogeneity from human heart and its catalytic efficacy in reducing hydroxyalkenals, related aldehydes and their glutathione adducts will be examined. For most metabolic studies 4-hydroxy-2-trans nonenal (HNE) will be used as a model unsaturated aldehyde. We will identify the major cellular metabolites of HNE isolated rat ventricular myocytes and assess the relative contribution of aldose reductase to HNE metabolism. In order to examine the efficiency of this enzyme in promoting HNE metabolism and minimizing its toxicity, the effects of inhibiting aldose reductase on HNE-induced myocyte hypercontracture and ATP depletion will be studied. During whole-cell patch-clamp, myocytes will be supplemented with aldose reductase to assess the role of this enzyme in attenuating the effects of HNE. In order to assess the, significance of aldose reductase- catalyzed reduction of HNE to cardiac oxidative injury we will examine the effects of aldose reductase inhibitors on the reperfusion injury to isolated perfused rat hearts. These studies will provide insights into the metabolic processes by which the heart detoxifies reactive aldehydes and help in understanding the role of these aldehydes as mediators of oxidative injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055477-05
Application #
6183944
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1998-12-01
Project End
2001-05-31
Budget Start
2000-04-01
Budget End
2001-05-31
Support Year
5
Fiscal Year
2000
Total Cost
$225,194
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Louisville
State
KY
Country
United States
Zip Code
40292
Riggs, Daniel W; Yeager, Ray A; Bhatnagar, Aruni (2018) Defining the Human Envirome: An Omics Approach for Assessing the Environmental Risk of Cardiovascular Disease. Circ Res 122:1259-1275
Hoetker, David; Chung, Weiliang; Zhang, Deqing et al. (2018) Exercise alters and ?-alanine combined with exercise augments histidyl dipeptide levels and scavenges lipid peroxidation products in human skeletal muscle. J Appl Physiol (1985) :
Mehra, Parul; Guo, Yiru; Nong, Yibing et al. (2018) Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair. Basic Res Cardiol 113:46
Baba, Shahid P; Zhang, Deqing; Singh, Mahavir et al. (2018) Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice. J Mol Cell Cardiol 118:183-192
Gibb, Andrew A; Epstein, Paul N; Uchida, Shizuka et al. (2017) Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth. Circulation 136:2144-2157
Tur, Jared; Chapalamadugu, Kalyan C; Katnik, Christopher et al. (2017) Kv?1.1 (AKR6A8) senses pyridine nucleotide changes in the mouse heart and modulates cardiac electrical activity. Am J Physiol Heart Circ Physiol 312:H571-H583
Bhatnagar, Aruni (2017) Environmental Determinants of Cardiovascular Disease. Circ Res 121:162-180
Nystoriak, Matthew A; Zhang, Deqing; Jagatheesan, Ganapathy et al. (2017) Heteromeric complexes of aldo-keto reductase auxiliary KV? subunits (AKR6A) regulate sarcolemmal localization of KV1.5 in coronary arterial myocytes. Chem Biol Interact 276:210-217
Gibb, Andrew A; Lorkiewicz, Pawel K; Zheng, Yu-Ting et al. (2017) Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes. Biochem J 474:2785-2801
Singh, Mahavir; Kapoor, Aniruddh; McCracken, James et al. (2017) Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages. Chem Biol Interact 265:16-23

Showing the most recent 10 out of 104 publications